Key result
The management of venous thromboembolism is rapidly evolving with new anticoagulant options, catheter-directed interventions, and clinical prediction models for long-term anticoagulation.
Why the study?
Venous thromboembolism management is rapidly evolving with new prevention options, diagnostic strategies, anticoagulants, and catheter-directed interventions.
This review highlights the evolving management of venous thromboembolism, including new anticoagulants, catheter-directed interventions, and clinical prediction models for long-term therapy.
Risk stratification may guide inpatient vs outpatient VTE decisions; leaves open need for prospective validation.
Venous thromboembolism (VTE) is a common vascular condition. New medications are available to prevent hospital-associated VTE. Strategies are being studied to increase appropriate diagnostic testing utilization. Management of deep vein thrombosis (DVT) and pulmonary embolism (PE) has evolved with the advent of new anticoagulant options and catheter-directed intervention. In light of this, providers are commonly challenged with the decision regarding inpatient versus outpatient management. Which patients require long-term (> 3 months) anticoagulation is challenging and multiple clinical prediction models may be used to help determine the risk-benefit ratio in each patient. The management of VTE is an ongoing area of research and is rapidly evolving.
No takes yet. Share an insight, caveat, or question.
Serhal et al. (2019) conducted a review in Venous thromboembolism (VTE). The management of venous thromboembolism is rapidly evolving with new anticoagulant options, catheter-directed interventions, and clinical prediction models for long-term anticoagulation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: